Asset sale Announced

Element Biosystems acquisition of Standard BioTools Mass Cytometry business

US$5.5m consideration

Announced 30 Sep 2026

Advisers

Standard BioTools Mass Cytometry business

Target

Not disclosed

Element Biosystems

Acquirer

Legal adviser

Other advisers

Financial adviser
DPO&Co
Target
Standard BioTools Mass Cytometry business
Acquirer
Element Biosystems
Seller
Standard BioTools
Target based in
United States
Buyer based in
United States
Seller based in
United States
Sector
Life Sciences
Tags
Life Sciences, Instrumentation

In the league tables

Similar deals

All life sciences deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.